Alternate Text DC Chemicals' products qualify for U.S. tariff exemptions. We guarantee no price increases due to customs duties and maintain stable supply, continuing to deliver reliable research solutions to our American clients.
Home > Inhibitors & Agonists > Others > Other Targets

Other Targets

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCY-048 Topotecan hydrochloride Featured Topotecan Hydrochloride (SKF 104864A Hydrochloride) is a Topoisomerase I inhibitor with potent antineoplastic activities.
DCD-082 γ- Mangostin >98%,Standard References
DCM-053 Brucine >98%,Standard References
DCM-051 Calceorioside B >98%,Standard References
DCG-016 Glibenclamide >98%,Standard References
DCS-011 Albiflorin >98%,Standard References
DCS-010 Paeoniflorin >98%,Standard References
DCQ-019 oxypaeoniflorin >98%,Standard References
DCH-008 Picroside Ⅱ >98%,Standard References
DCW-001 Schisandrin B >98%,Standard References
DCM-031 magnolin >98%,Standard References
DCT-009 Pseudolaric Acid B >98%,Standard References
DCY-125 Protostemotinine >98%,Standard References
DCW-034 Schisanhenol >98%,Standard References
DCS-042 Sudan IV;Solvent Red 24 >98%,Standard References
DCY-092 iridin >98%,Standard References
DCY-180 3-isomangostin >98%,Standard References
DCS-073 Mulberroside C >98%,Standard References
DCH-007 PicrosideⅠ >98%,Standard References
DCO-002 Levistilide A >98%,Standard References
DCB-087 Praeruptorin E >98%,Standard References
DCH-020 Harpagoside >98%,Standard References
DCY-155 Eupalinolide B Featured >98%,Standard References
DCC-048 Acevaltrate >98%,Standard References
DCZ-041 Resibufogenin >98%,Standard References
DCS-068 Bufarenogin >98%,Standard References
DCZ-115 Schisandrin >98%,Standard References
DCY-164 Telocinobufagin >98%,Standard References
DCR-041 Gamabufotalin >98%,Standard References
DCR-033 Gamabufalin >98%,Standard References

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X